Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215403 · ClinicalTrials.gov registry record · Phase 2
Prescriptive Infusion Algorithm (PIA)
A Phase 2 study, sponsored by AskBio.
- Not yet
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT07215403 is a Phase 2 study that has not yet begun recruiting, run by AskBio. The registered enrollment target is 18 participants.
The verdict
NCT07215403, a Phase 2 study, has not yet begun recruiting, sponsored by AskBio.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is being done to test a new way of delivering AB-1005 into the brain. The goal is to make the procedure easier and quicker to perform, while providing similar amounts of drug to the part of the brain that needs treatment. Technical (Stage 0) To test if the new delivery method (prefrontal surgical approach) can consistently deliver AB-1005 to the putamen using MRI monitoring. Technical (Stage 1) To test if the new delivery method (PIA-based infusion) can consistently deliver AB-1005 to the putamen using brain imaging by MRI. Technical (Stage 2) To confirm the new delivery method works without brain imaging by MRI, using standard operating room tools including brain imaging by CT. Safety (Stage 1 and 2) To assess the safety and tolerability of the new delivery method for AB-1005 up to 6 months after surgery
Interventions
- PROCEDURE Prescriptive Infusion Algorithm
- DRUG AB-1005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215403
The ClinicalTrials.gov registry entry for NCT07215403 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AskBio, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prescriptive Infusion Algorithm is the first listed.
NCT07215403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07215403 about?
NCT07215403 is a clinical study titled "Prescriptive Infusion Algorithm (PIA)". This study is being done to test a new way of delivering AB-1005 into the brain. The goal is to make the procedure easier and quicker to perform, while providing similar amounts of drug to the part of the brain that needs treatment. Technical (Stage 0) To test if the new delivery method (prefrontal...
What is the current status of trial NCT07215403?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2026-07-15. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07215403?
The interventions under investigation include: Prescriptive Infusion Algorithm (PROCEDURE), AB-1005 (DRUG).
Who is sponsoring clinical trial NCT07215403?
This trial is sponsored by AskBio, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.